ArticleJournal of clinical medicine2022

Evaluation of FMR4, FMR5 and FMR6 Expression Levels as Non-Invasive Biomarkers for the Diagnosis of Fragile X-Associated Primary Ovarian Insufficiency (FXPOI).

Maria Isabel Alvarez-Mora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.